Exact Mass: 266.1001628
Exact Mass Matches: 266.1001628
Found 255 metabolites which its exact mass value is equals to given mass value 266.1001628
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Benzarone
C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
(S)-Pterosin K
(S)-Pterosin K is found in green vegetables. (S)-Pterosin K is a constituent of the leaves of Pteridium aquilinum (bracken fern). Constituent of the leaves of Pteridium aquilinum (bracken fern). (S)-Pterosin K is found in green vegetables and root vegetables.
7-Methoxy-2-methylisoflavone
7-Methoxy-2-methylisoflavone is found in herbs and spices. 7-Methoxy-2-methylisoflavone is isolated from Glycyrrhiza glabra (licorice). Isolated from Glycyrrhiza glabra (licorice). 7-Methoxy-2-methylisoflavone is found in tea and herbs and spices.
(E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol
(E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol is found in green vegetables. (E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol is produced by asparagus (Asparagus officinalis) cell cultures. Production by asparagus (Asparagus officinalis) cell cultures. (E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol is found in green vegetables.
1-(3-Carboxypropyl)-3,7-dimethylxanthine
7-Deaza-2'-deoxyguanosine
Doxofylline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D019141 - Respiratory System Agents > D000996 - Antitussive Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D002491 - Central Nervous System Agents Doxofylline is an orally active PDE IV inhibitor and A1AR antagonist. Doxofylline reduces inflammation in epithelial cells via inhibiting mitochondrial ROS production and amelioration of multiple cellular pathways (NLRP3-TXNIP inflammasome activation). Doxophylline can be used in studies of asthma, chronic obstructive pulmonary disease, and bronchospasm[1][2][3].
Forodesine
Miroprofen
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
2,2-Dimethylpropanal 2,4-dinitrophenylhydrazone
(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid
[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 3-hydroxybutanoate
5-Methyl-7-methoxyisoflavone
5-Methyl-7-methoxyisoflavone is a sensational, non-steroidal anabolic isoflavone. 5-Methyl-7-methoxyisoflavone shows potency increasing muscle mass and endurance[1]. 5-Methyl-7-methoxyisoflavone is a sensational, non-steroidal anabolic isoflavone. 5-Methyl-7-methoxyisoflavone shows potency increasing muscle mass and endurance[1].
3-(hydroxymethyl)-5-(6-hydroxy-9h-purin-9-yl)cyclopentane-1,2-diol
2,6-Bis[(2-hydroxyethyl)amino]-3-nitrobenzonitrile
1-(3-Carboxypropyl)-3,7-dimethylxanthine
CONFIDENCE standard compound; INTERNAL_ID 2785 INTERNAL_ID 2785; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 8711
2,5-dihydroxy-3,6-bis(3-methylbut-3-en-1-ynyl)benzaldehyde|sterehirsutinal
dracorhodin
Dracorhodin is a natural product found in Calamus draco with data available.
(Z)-3,4,4-trihydroxy-1,5-diphenylpent-3-en-1-yn|lawsochylin B
beta-Methyl-crotonsaeure-(5-benzoyl-penta-2,4-diin-yl-ester)|beta-Methyl-crotonsaeure-<5-benzoyl-penta-2,4-diin-yl-ester>
1-(3,4-dihydroxyphenyl)-5-(4-hydroxyphenyl)pent-1-en-4-yne
Tyrphostin AG 1296
D000970 - Antineoplastic Agents > D020032 - Tyrphostins
RG-13022
D000970 - Antineoplastic Agents > D020032 - Tyrphostins
2-Phenethyl-6-hydroxychromone
2-Phenethyl-6-hydroxychromone is a natural product found in Aquilaria sinensis with data available.
Z-Asn-OH
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.482 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.481 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.477 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.480
4,6-Dimethyl-3(4-hydroxyphenyl)coumarin
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.142 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.141 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.139
5-(3,4-Dihydroxy-1,5-cyclohexadien-1-yl)-5-ethylbarbituric acid
(E)-4-[5-(4-Hydroxyphenoxy)-3-penten-1-ynyl]phenol
4H-1-Benzopyran-4-one,7-hydroxy-2-(4-methoxyphenyl)-
2-[butyl[4-(2,2-dicyanovinyl)-3-methylphenyl]amino]ethyl (3,4-dichlorophenyl)carbamate
BENZOFURAN-2-CARBOXYLIC AXID (4-AMINO-2-METHYL-PHENYL)-AMINE
7-Deaza-2-deoxyguanosine
3-(morpholin-4-ylcarbonyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-amine(SALTDATA: FREE)
C13H18N2O2S (266.10889280000004)
Phenol,4-amino-2-[(diethylamino)methyl]-, hydrochloride (1:2)
2-PHENYL-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER
(2-P-TOLYL-IMIDAZO[1,2-A]PYRIDIN-3-YL)-ACETIC ACID
furaprofen
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
1H-Purine-8-butanoicacid, 2,3,6,9-tetrahydro-1,3-dimethyl-2,6-dioxo-
2-(3-METHYL-1,2,4-OXADIAZOL-5-YL)ETHANAMINE HYDROCHLORIDE
1-Chlorocarbonyl-4-piperidinopiperidine hydrochloride
5-(PIPERIDIN-1-YLSULFONYL)INDOLINE
C13H18N2O2S (266.10889280000004)
2-methylidene-4-oxo-4-(4-phenylphenyl)butanoic acid
tubercidin
An N-glycosylpyrrolopyrimidine that is adenosine in which the in the 5-membered ring that is not attached to the ribose moiety is replaced by a carbon. Tubercidin is produced in the culture broth of Streptomyces tubericidus. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Tubercidin (7-Deazaadenosine) is an antibiotic obtained from Streptomyces tubercidicus. Tubercidin inhibits the growth of Streptococcus faecalis (8043) with an IC50 of 0.02 μM[1]. Tubercidin inhibits polymerases by incorporating DNA or RNA, thereby inhibiting DNA replication, RNA and protein synthesis[2]. Tubercidin is a weak inhibitor of adenosine phosphorylase, and interferes with the phosphorylation of adenosine and AMP[1]. Tubercidin has antiviral activity[2]. Tubercidin (7-Deazaadenosine) is an antibiotic obtained from Streptomyces tubercidicus. Tubercidin inhibits the growth of Streptococcus faecalis (8043) with an IC50 of 0.02 μM[1]. Tubercidin inhibits polymerases by incorporating DNA or RNA, thereby inhibiting DNA replication, RNA and protein synthesis[2]. Tubercidin is a weak inhibitor of adenosine phosphorylase, and interferes with the phosphorylation of adenosine and AMP[1]. Tubercidin has antiviral activity[2].
N-(cyclohexylideneamino)-4-methyl-benzenesulfonamide
C13H18N2O2S (266.10889280000004)
1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-butyric acid
1-PHENYL-IMIDAZO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER
1H-PYRROLO[2,3-B]PYRIDINE, 4-CHLORO-1-[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]-
1H-Pyrrolo[2,3-b]pyridine, 5-chloro-1-[(1,1-dimethylethyl)dimethylsilyl]-
2,4-DIHYDRO-5-(4-METHOXYPHENYL)-2-PHENYL-3H-PYRAZOL-3-ONE
Ethyl 6-phenylimidazo[1,2-a]pyridine-2-carboxylate
(S)-6-(((Allyloxy)carbonyl)amino)-2-aminohexanoic acid hydrochloride
2,6-DIMETHYL-4-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-4-OL
4H-1-Benzopyran-4-one,7-methoxy-3-methyl-2-phenyl-
ethyl 5-phenyl-1H-pyrrolo[2,3-c]pyridine-2-carboxylate
9H-Purine, 6-methyl-9-b-D-ribofuranosyl-
6-Methylpurine riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
1-(METHYLSULFONYL)SPIRO[INDOLINE-3,4-PIPERIDINE]
C13H18N2O2S (266.10889280000004)
3-PHENYLMETHYL-3,4-DIHYDRO-1,4-BENZODIAZEPIN-2,5-DIONE
3,5-bis(ethoxycarbonyl)phenylboronic acid
C12H15BO6 (266.09616400000004)
1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylic acid
C13H15FN2O3 (266.10666519999995)
4-methoxy-6-(5-phenyl-1,2-dihydropyrazol-3-ylidene)cyclohexa-2,4-dien-1-one
4-(1,3-benzodioxol-5-yl)-2,3-dihydro-1H-1,5-benzodiazepine
2-(4-METHOXY-PHENYL)-6-METHYL-IMIDAZO[1,2-A]-PYRIDINE-3-CARBALDEHYDE
1-ethyl-2-naphthalen-1-ylimidazole-4-carboxylic acid
3-ethyl-2-naphthalen-1-ylimidazole-4-carboxylic acid
N-Methyl-4-[5-(trifluoromethyl)pyridin-2-yl]benzylamine
2H-1-Benzopyran-2-one,7-hydroxy-4-methyl-3-(phenylmethyl)-
1-(3-Fluoro-4-methoxyphenyl)-4-oxocyclohexanecarboxylic acid
5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one
C13H18N2O2S (266.10889280000004)
4-{5-[(1E)-prop-1-en-1-yl]-1-benzofuran-2-yl}benzene-1,3-diol
7-[(2S,3S,4S,5S)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one
Doxofylline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D019141 - Respiratory System Agents > D000996 - Antitussive Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D002491 - Central Nervous System Agents Doxofylline is an orally active PDE IV inhibitor and A1AR antagonist. Doxofylline reduces inflammation in epithelial cells via inhibiting mitochondrial ROS production and amelioration of multiple cellular pathways (NLRP3-TXNIP inflammasome activation). Doxophylline can be used in studies of asthma, chronic obstructive pulmonary disease, and bronchospasm[1][2][3].
(-)-Microperfuranone
A butenolide that is furan-2(5H)-one which is substituted by a phenyl group at position 3, a benzyl group at position 4, and a hydroxy group at position 5 (the (-)-enantiomer). A secondary metabolite obtained from Aspergillus nidulans.
3-Benzyl-3,6-dihydroxy-6-(hydroxymethyl)-diketopiperazine
(2S,3R,4S,5R)-2-(5-hydroxy-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] butanoate
(2,4,5,6-Tetrahydroxy-1-oxohexan-3-yl) 2-hydroxybutanoate
[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 3-hydroxybutanoate
3-(4H-imidazol-4-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoic acid
5-[(4-Methylphenoxy)methyl]-3-phenyl-1,2,4-oxadiazole
3-(4-Methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole
6-(4-ethoxy-1H-quinazolin-2-ylidene)-1-cyclohexa-2,4-dienone
2-(1,2-benzoxazol-3-yl)-N-(3-methylphenyl)acetamide
(2S,3R,4R,4aS,5S,6R,7S,8aR)-6-methylhexahydro-2H-1-benzopyran-2,3,4,4a,5,6,7(5H)-heptol
1-methyl-1-(oxidoamino)-3-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea
1-Methyl-1-(oxidoamino)-3-[2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea
1-methyl-1-(oxidoamino)-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea
4-(oxidoamino)-2,5-diphenyl-1H-pyrazol-3-one
C15H12N3O2- (266.09294719999997)
Benzarone
C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents
Miroprofen
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran
A member of the class of benzofurans that is 1-benzofuran substituted by a 2,4-dihydroxyphenyl group at position 2 and a prop-1-en-1-yl group at position 5. It is a lignan derivative isolated from the roots of Krameria lappacea.
dehydrodeoxycoformycin
A coformycin that is dehydrocoformycin with the hydroxy group at position 2 replaced with a hydrogen.
10-methoxy-6h,7h,12h-indolo[2,3-a]quinolizin-4-one
8-hydroxy-3-(2-phenylethenyl)-3,4-dihydro-2-benzopyran-1-one
(2s,3s,4s)-3-(carboxymethyl)-4-(6-hydroxypyridin-3-yl)pyrrolidine-2-carboxylic acid
4-[(3e)-5-(4-hydroxyphenoxy)pent-3-en-1-yn-1-yl]phenol
asparenydiol
{"Ingredient_id": "HBIN017122","Ingredient_name": "asparenydiol","Alias": "NA","Ingredient_formula": "C17H14O3","Ingredient_Smile": "C1=CC(=CC=C1C#CC=CCOC2=CC=C(C=C2)O)O","Ingredient_weight": "266.29 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1885","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10084256","DrugBank_id": "NA"}